AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
4.610
0.00 (0.00%)
Jul 24, 2026, 4:00 PM EDT - Market closed
AVITA Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '21 Jun 30, 2021 |
| 72.35 | 71.61 | 64.25 | 50.14 | 34.42 | 29.23 | |
Revenue Growth (YoY) | 0.96% | 11.45% | 28.14% | 45.68% | 17.75% | 104.95% |
Cost of Revenue | 13.48 | 12.79 | 9.09 | 7.78 | 6.04 | 5.95 |
Gross Profit | 58.86 | 58.82 | 55.16 | 42.36 | 28.38 | 23.28 |
Selling, General & Admin | 78.19 | 80.51 | 91.39 | 65.63 | 45.24 | 37.06 |
Research & Development | 20.19 | 20.84 | 20.36 | 20.82 | 13.86 | 14.82 |
Other Operating Expenses | - | - | - | -1.43 | -3.22 | -2.06 |
Total Operating Expenses | 98.38 | 101.35 | 111.75 | 85.02 | 55.89 | 49.82 |
Operating Income | -39.51 | -42.53 | -56.59 | -42.66 | -27.51 | -26.54 |
Interest Income | - | - | 0.16 | 8.48 | 0.89 | 0.02 |
Interest Expense | -5.19 | -5 | -5.36 | -1.14 | -0.02 | -0.02 |
Other Non-Operating Income (Expense) | - | -1.04 | - | - | - | - |
Total Non-Operating Income (Expense) | -5.19 | -6.04 | -5.2 | 7.34 | 0.88 | -0.01 |
Pretax Income | -45.35 | -48.58 | -61.79 | -35.32 | -26.63 | -26.55 |
Provision for Income Taxes | - | 0.01 | 0.05 | 0.07 | 0.04 | 0.04 |
Net Income | -45.35 | -48.59 | -61.85 | -35.38 | -26.67 | -26.58 |
Net Income to Common | -10.61 | -48.59 | -61.85 | -35.38 | -26.67 | -26.58 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 |
Shares Change (YoY) | 11.08% | 7.64% | 2.18% | 1.32% | 10.26% | 11.75% |
EPS (Basic) | -31.40 | -34.80 | -47.80 | -28.00 | -21.40 | -23.40 |
EPS (Diluted) | -31.40 | -34.80 | -47.80 | -28.00 | -21.40 | -23.40 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -45.02 | -48.59 | -61.85 | -35.38 | -26.67 | -26.58 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -31.13 | -34.88 | -47.79 | -27.93 | -21.33 | -23.45 |
Gross Margin | 81.36% | 82.13% | 85.85% | 84.48% | 82.45% | 79.65% |
Operating Margin | -54.62% | -59.40% | -88.08% | -85.07% | -79.91% | -90.79% |
Profit Margin | -62.68% | -67.85% | -96.26% | -70.56% | -77.47% | -90.94% |
FCF Margin | -62.23% | -67.85% | -96.26% | -70.56% | -77.47% | -90.94% |
EBITDA | -39.51 | -42.53 | -56.59 | -42.66 | -27.51 | -26.54 |
EBIT | -39.51 | -42.53 | -56.59 | -42.66 | -27.51 | -26.54 |
EBIT Margin | -54.62% | -59.40% | -88.08% | -85.07% | -79.91% | -90.79% |
Effective Tax Rate | - | -0.02% | -0.09% | -0.19% | -0.14% | -0.14% |